Enzon Pharmaceuticals buy DomRuinart
Start price
01.12.20
/
50%
€0.12
Target price
01.12.21
€0.000
Performance (%)
49.17%
End price
14.12.20
€0.18
Summary
This prediction ended on 14.12.20 with a price of €0.18. With a performance of 49.17% the BUY prediction by DomRuinart was a big success. DomRuinart has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Enzon Pharmaceuticals | -23.077% | -23.077% | -65.517% | -77.876% |
| iShares Core DAX® | 1.001% | -1.218% | 13.263% | 60.023% |
| iShares Nasdaq 100 | -1.447% | -4.597% | 0.414% | 85.321% |
| iShares Nikkei 225® | 8.406% | 8.425% | 27.328% | 61.038% |
| iShares S&P 500 | -0.226% | -2.451% | 0.167% | 57.738% |
According to DomRuinart what are the pros and cons of Enzon Pharmaceuticals for the foreseeable future?
Pros
Could be worthwhile Investment >10% per year
Cons
Comments by DomRuinart for this prediction
In the thread Enzon Pharmaceuticals diskutieren
Buy mit Kursziel 0,0